Literature DB >> 6965234

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.

G Fossati1, A Balsari, D Taramelli, M L Sensi, G Pellegris, M Nava, G Parmiani.   

Abstract

Peripheral blood lymphocytes (PBL) of melanoma patients were sensitized in vitro with lymphocytes of a single donor or with a pool of lymphocytes of 5-20 different donors. After 6-7 days, the cytotoxic activity of the sensitized PBL was tested against cultured autologous tumor cells and lymphocytes in a 51Cr-release assay. Tumor lysis was observed in 13 of 16 cases in which patients' PBL (Pt-PBL) were stimulated by a pool of allogeneic lymphocytes and in five out of seven cases when single sensitization was performed. In no case was lysis of autologous normal lymphocytes or blasts seen. Cultivation of Pt-PBL with irradiated autologous tumor cells never led to the induction of lymphocytes cytotoxic to melanoma cells. Lysability by pool-activated autologous Pt-PBL of fresh cryopreserved tumor cells was compared to that of short-term cultured tumor cells, and no significant differences were observed. Cold-target inhibition experiments indicated that the cytotoxicity of Pt-PBL was tumor-restricted since only autologous melanoma cells but not lymphocytes were able to inhibit the reaction. These results indicate that activation of Pt-PBL is necessary in order to elicit or amplify their antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6965234     DOI: 10.1007/BF00200176

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

1.  Specificity of cellular immune reactivity to virus-induced tumours.

Authors:  M O de Landazuri; R B Herberman
Journal:  Nat New Biol       Date:  1972-07-05

2.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells.

Authors:  J M Zarling; H I Robins; P C Raich; F H Bach; M L Bach
Journal:  Nature       Date:  1978-07-20       Impact factor: 49.962

3.  Original H-2d and alien H-2k-like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell-mediated immunity.

Authors:  M Sensi; G Carbone; G Parmiani
Journal:  Eur J Immunol       Date:  1980-09       Impact factor: 5.532

4.  Specific T-cell-mediated killing of autologous lung tumour cells.

Authors:  B M Vose
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

5.  Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.

Authors:  P A Paciucci; S Macphail; J M Zarling; F H Bach
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

6.  Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.

Authors:  B M Vose; F Vanky; E Klein
Journal:  Int J Cancer       Date:  1977-10-15       Impact factor: 7.396

7.  Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.

Authors:  J M Zarling; P C Kung
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

8.  Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity.

Authors:  F T Vánky; B M Vose; M Fopp; E Klein
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

9.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.

Authors:  A Mazumder; E A Grimm; H Z Zhang; S A Rosenberg
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

10.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  13 in total

1.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.

Authors:  D Taramelli; A Mazzocchi; C Clemente; G Fossati; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 3.  Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?

Authors:  B M Vose
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.

Authors:  B Leshem; B Gotsman; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.

Authors:  M P Colombo; M Parenza; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.

Authors:  M Sensi; L Grazioli; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.

Authors:  A Balsari; R Marolda; C Gambacorti-Passerini; G Sciorelli; G Tona; E Cosulich; D Taramelli; G Fossati; G Parmiani; N Cascinelli
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.

Authors:  B M Vose; W White
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  High incidence of chromosomal lesions involving C-heterochromatin in four human melanoma lines.

Authors:  L Larizza; L Doneda; M Rodolfo; G Fossati
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

10.  Lysis of autologous tumor cells by blood lymphocytes activated in autologous mixed lymphocyte tumor cell culture--no correlation with the postsurgical clinical course.

Authors:  F Vánky; E Klein; J Willems; K Böök; T Ivert; A Péterffy; U Nilsonne; A Kreicbergs
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.